Tenaya Therapeutics Prices $180M IPO for Targeted Therapies

https://www.drugdeliverybusiness.com/tenaya-therapeutics-prices-180m-ipo-for-targeted-therapies/
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.